Semantic Scholar uses AI to extract papers important to this topic.
Apixaban, an oral factor Xa inhibitor administered in fixed doses, may simplify the treatment of venous… Expand BACKGROUND
Whether the oral factor Xa inhibitor edoxaban can be an alternative to warfarin in patients with venous… Expand BACKGROUND
Rivaroxaban, an oral factor Xa inhibitor, may provide a simple, fixed-dose regimen for treating acute deep-vein… Expand BACKGROUND
The direct oral thrombin inhibitor dabigatran has a predictable anticoagulant effect and may be an alternative therapy… Expand This article discusses the prevention of venous thromboembolism (VTE) and is part of the Antithrombotic and Thrombolytic Therapy… Expand This article discusses the prevention of venous thromboembolism (VTE) and is part of the Seventh American College of Chest… Expand BACKGROUND
Patients with cancer have a substantial risk of recurrent thrombosis despite the use of oral anticoagulant therapy. We… Expand A small proportion of patients with deep vein thrombosis develop recurrent venous thromboembolic complications or bleeding during… Expand BACKGROUND
Little is known about the prognosis of cancer discovered during or after an episode of venous thromboembolism… Expand CONTEXT
Observational studies have found lower rates of coronary heart disease (CHD) in postmenopausal women who take estrogen… Expand